(Q43010204)

12 November 2017

0 references

Gastrointestinal stromal tumour treated with neoadjuvant imatinib (English)

1 reference

12 November 2017

Loughrey MB

1

1 reference

12 November 2017

Mitchell C

2

1 reference

12 November 2017

Mann GB

3

1 reference

12 November 2017

Michael M

4

1 reference

12 November 2017

Waring PM

5

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

Journal of Clinical Pathology

12 November 2017

1 reference

12 November 2017

58

1 reference

12 November 2017

7

1 reference

12 November 2017

779-781

1 reference

Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy

12 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770717

Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770717

Is there a role for surgery in patients with "unresectable" cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate?

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770717

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770717

Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770717

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770717

Neoadjuvant imatinib for unresectable gastrointestinal stromal tumor.

26 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770717

Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1770717

Diagnosis of gastrointestinal stromal tumors: A consensus approach

3 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15976351

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/JCP.2004.023226

1 reference

12 November 2017

1 reference

12 November 2017

PubMed publication ID

15976351

1 reference